Literature DB >> 22017305

Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran.

Mohammad-Reza Azhar1, Zohreh Rahimi, Asad Vaisi-Raygani, Reza Akramipour, Hamid Madani, Ziba Rahimi, Abbas Parsian.   

Abstract

AIMS: Polymorphism in genes involved in folate metabolism may influence the susceptibility to acute lymphoblastic leukemia (ALL). The aim of the present study was to determine the role of the two most common polymorphisms of the 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene, MTHFR C677T and A1298C, and their interaction on the susceptibility to ALL.
METHODS: Seventy-two children with ALL and 109 age- and sex-matched healthy children from Western Iran were screened for MTHFR C677T and A1298C variants by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: The frequencies of MTHFR 677T and 1298C alleles in patients were 29.9% and 43.1%, respectively, that were higher than those in controls (24.8% and 38.1%, respectively). Logistic regression analysis was performed and its result in the odds ratios (ORs) for possession of either MTHFR 677T or 1298C allele was found to be 1.98 [95% confidence interval (CI) 0.72-5.4, p = 0.18] and 1.48 (95% CI 0.59-3.69, p = 0.4), respectively. Also the concomitant presence of both MTHFR 677T and 1298C alleles was not associated with the risk of ALL [OR = 2.12 (95% CI 0.8-5.7, p = 0.13)].
CONCLUSION: Our results in a homogenous population with Kurdish ethnic background indicated that neither the MTHFR 677T allele nor the MTHFR 1298C allele is associated with increased risk of ALL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017305     DOI: 10.1089/gtmb.2011.0041

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

Review 1.  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Atsushi Manabe; Shuki Mizutani
Journal:  Int J Hematol       Date:  2012-12-13       Impact factor: 2.490

2.  Lack of Impact of the A1298C MTHFR on the Risk of Childhood Acute Lymphoblastic Leukemia: Evidence from a Meta-analysis.

Authors:  Rim Frikha
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-26       Impact factor: 0.900

Review 3.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

4.  MTHFR gene polymorphism in acute lymphoblastic leukemia among North Indian children: a case-control study and meta-analysis updated from 2011.

Authors:  Nirmalya Roy Moulik; Farah Parveen; Archana Kumar; Shally Awasthi; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2014-06-12       Impact factor: 3.172

5.  The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.

Authors:  Jen-Sheng Pei; Chin-Mu Hsu; Chia-Wen Tsai; Wen-Shin Chang; Hong-Xue Ji; Chieh-Lun Hsiao; Chia-En Miao; Yuan-Nian Hsu; Da-Tian Bau
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Association between Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Susceptibility to Childhood Acute Lymphoblastic Leukemia in an Iranian Population.

Authors:  Gholamreza Bahari; Mohammad Hashemi; Majid Naderi; Mohsen Taheri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-07-01

7.  Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.

Authors:  Su-yi Li; Jie-yu Ye; En-yu Liang; Li-xia Zhou; Mo Yang
Journal:  Med Sci Monit       Date:  2015-03-12

8.  Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukaemia (ALL) in Chinese population.

Authors:  Xiaolei Li; Qingchuan Liao; Shunguo Zhang; Minling Chen
Journal:  Eur J Med Res       Date:  2014-01-29       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.